| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.12B | 91.35B | 92.42B | 96.30B | 106.20B | 66.07B |
| Gross Profit | 20.90B | 19.83B | 18.30B | 18.01B | 15.37B | 11.85B |
| EBITDA | 15.87B | 16.94B | 14.67B | 15.29B | 12.78B | 9.30B |
| Net Income | 7.96B | 8.38B | 6.17B | 6.46B | 4.77B | 2.85B |
Balance Sheet | ||||||
| Total Assets | 122.26B | 127.77B | 119.45B | 111.44B | 109.82B | 99.10B |
| Cash, Cash Equivalents and Short-Term Investments | 36.80B | 38.90B | 34.10B | 28.73B | 24.64B | 23.71B |
| Total Debt | 1.89B | 877.00M | 913.00M | 926.00M | 953.00M | 1.00B |
| Total Liabilities | 17.68B | 18.88B | 20.04B | 18.51B | 23.44B | 16.98B |
| Stockholders Equity | 101.42B | 105.44B | 96.45B | 90.36B | 84.28B | 78.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.71B | 7.96B | 4.67B | 6.21B | 1.23B |
| Operating Cash Flow | 0.00 | 15.91B | 13.84B | 11.83B | 12.17B | 6.44B |
| Investing Cash Flow | 0.00 | -13.26B | -6.03B | -8.98B | -9.67B | -7.07B |
| Financing Cash Flow | 0.00 | -1.62B | -1.49B | -1.26B | -1.87B | -961.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥129.45B | 12.17 | ― | 1.22% | -3.37% | 19.40% | |
76 Outperform | ¥95.01B | 8.94 | 9.07% | 3.61% | 9.39% | 77.24% | |
75 Outperform | ¥112.26B | 8.99 | 7.99% | 3.89% | 1.08% | 37.11% | |
74 Outperform | ¥77.58B | 19.04 | ― | 2.88% | 2.77% | 10.64% | |
73 Outperform | ¥472.11B | 28.19 | 6.03% | 1.81% | 7.08% | 43.50% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | ¥41.66B | -28.83 | ― | 1.81% | 0.93% | 1212.45% |